Publications by authors named "Merle Diamond"

Claim this Profile
C
Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.
Andrew M Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Merle Diamond

Pain Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.
Andrew M Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Merle Diamond

Pain Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.
Stewart J Tepper, Merle L Diamond, Joe Hirman, Divya Asher, Damian Fiore

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial.
Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Merle Diamond

Cephalalgia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.
Michael J Marmura, Hans-Christoph Diener, Robert P Cowan, Stewart J Tepper, Merle L Diamond

Headache· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, Robert Cowan, Amaal J Starling, Merle L Diamond

Headache· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
Stephen Silberstein, Merle Diamond, Nada A Hindiyeh, David M Biondi, Roger Cady

J Headache Pain· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to the Identification and Differentiation of Migraine.
Merle L Diamond, Susan Hutchinson

J Fam Pract· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing and understanding adult headache.
Alexander Feoktistov, Merle Diamond

Otolaryngol Clin North Am· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Roger K Cady, Merle L Diamond, Michael P Diamond, Jeanne E Ballard, Michelle E Lener

Headache· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Lisa K Mannix, Vincent T Martin, Roger K Cady, Merle L Diamond, Shelly E Lener

Obstet Gynecol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the emergency department for severe headache. A population-based study.
Benjamin W Friedman, Daniel Serrano, Michael Reed, Merle Diamond, Richard B Lipton

Headache· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
Fred Freitag, Merle Diamond, Seymour Diamond, Imke Janssen, Anthony Rodgers

Headache· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine frequency and health utilities: findings from a multisite survey.
Jeffrey S Brown, Peter J Neumann, George Papadopoulos, Gary Ruoff, Merle Diamond

Value Health· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
Frederick G Freitag, Seymour Diamond, Merle Diamond, George Urban

Headache· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Merle L Diamond, Roger K Cady, Lian Mao, David M Biondi, Gary Finlayson

Headache· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of migraine on the health and well-being of women.
Merle Diamond

J Womens Health (Larchmt)· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
Carl Dahlöf, Elizabeth Loder, Merle Diamond, Marcia Rupnow, George Papadopoulos

Health Qual Life Outcomes· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Jan Lewis Brandes, Timothy Smith, Merle Diamond, Michael H Ames

Headache· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
Timothy Smith, Harvey Blumenthal, Merle Diamond, Alexander Mauskop, Michael Ames

Headache· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Frederick G Freitag, Gary Finlayson, Alan M Rapoport, Arthur H Elkind, Merle L Diamond

Headache· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing migraine therapy: evidence-based and patient-centered care.
Merle L Diamond, Richard G Wenzel, George R Nissan

Expert Rev Neurother· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial--a comment.
Harvey J Blumenthal, Merle L Diamond

Headache· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topiramate improves health-related quality of life when used to prevent migraine.
Merle Diamond, Carl Dahlöf, George Papadopoulos, Walter Neto, S-C Wu

Headache· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine during pregnancy: options for therapy.
Anthony W Fox, Merle L Diamond, Egilius L H Spierings

CNS Drugs· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis